XML 74 R104.htm IDEA: XBRL DOCUMENT v3.19.3
Supplemental Condensed Consolidating Financial Information (Schedule of Condensed Consolidating Statement of Cash Flows) (Details) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net cash (used in) provided by operating activities $ 191 $ 440
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (13) (21)
Purchases of property and equipment (322) (413)
Proceeds from disposition of hospitals and other ancillary operations 363 228
Proceeds from sale of property and equipment 1 7
Purchases of available-for-sale securities and equity securities (58) (50)
Proceeds from sales of available-for-sale securities and equity securities 72 75
Increase in other investments (146) (76)
Net cash used in investing activities (103) (250)
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (1)
Deferred financing costs and other debt-related costs (28) (93)
Proceeds from noncontrolling investors in joint ventures 10 2
Redemption of noncontrolling investments in joint ventures (6) (27)
Distributions to noncontrolling investors in joint ventures (78) (74)
Proceeds from sale-lease back 56  
Borrowings under credit agreements 26 24
Issuance of long-term debt 2,489 1,033
Proceeds from ABL facility 25 587
Repayments of long-term indebtedness (2,620) (1,869)
Net cash used in financing activities (127) (418)
Net change in cash and cash equivalents (39) (228)
Cash and cash equivalents at beginning of period 196 563
Cash and cash equivalents at end of period 157 335
Parent Guarantor [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 5 45
Cash flows from financing activities:    
Repurchase of restricted stock shares for payroll tax withholding requirements (1) (1)
Changes in intercompany balances with affiliates, net (4) (44)
Net cash used in financing activities (5) (45)
Issuer [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities (431) (250)
Cash flows from investing activities:    
Proceeds from disposition of hospitals and other ancillary operations 18  
Net cash used in investing activities 18  
Cash flows from financing activities:    
Deferred financing costs and other debt-related costs (28) (93)
Changes in intercompany balances with affiliates, net 508 (10)
Issuance of long-term debt 2,489 1,033
Proceeds from ABL facility 25 538
Repayments of long-term indebtedness (2,581) (1,218)
Net cash used in financing activities 413 250
Other Guarantor [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 579 653
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (6) (3)
Purchases of property and equipment (267) (312)
Proceeds from disposition of hospitals and other ancillary operations 30  
Proceeds from sale of property and equipment 1 4
Purchases of available-for-sale securities and equity securities (15) (30)
Proceeds from sales of available-for-sale securities and equity securities 27 55
Increase in other investments (104) (50)
Net cash used in investing activities (334) (336)
Cash flows from financing activities:    
Changes in intercompany balances with affiliates, net (333) 29
Proceeds from sale-lease back 56  
Borrowings under credit agreements 25 22
Proceeds from ABL facility   49
Repayments of long-term indebtedness (33) (643)
Net cash used in financing activities (285) (543)
Net change in cash and cash equivalents (40) (226)
Cash and cash equivalents at beginning of period 132 470
Cash and cash equivalents at end of period 92 244
Non-Guarantor Subsidiaries [Member]    
Cash flows from operating activities:    
Net cash (used in) provided by operating activities 38 (8)
Cash flows from investing activities:    
Acquisitions of facilities and other related businesses (7) (18)
Purchases of property and equipment (55) (101)
Proceeds from disposition of hospitals and other ancillary operations 315 228
Proceeds from sale of property and equipment   3
Purchases of available-for-sale securities and equity securities (43) (20)
Proceeds from sales of available-for-sale securities and equity securities 45 20
Increase in other investments (42) (26)
Net cash used in investing activities 213 86
Cash flows from financing activities:    
Proceeds from noncontrolling investors in joint ventures 10 2
Redemption of noncontrolling investments in joint ventures (6) (27)
Distributions to noncontrolling investors in joint ventures (78) (74)
Changes in intercompany balances with affiliates, net (171) 25
Borrowings under credit agreements 1 2
Repayments of long-term indebtedness (6) (8)
Net cash used in financing activities (250) (80)
Net change in cash and cash equivalents 1 (2)
Cash and cash equivalents at beginning of period 64 93
Cash and cash equivalents at end of period $ 65 $ 91